Canadian Consensus Conference on Coronary Thrombolysis--1994 recommendations. National Health Research and Development Program.
D000277:Adjuvants, Pharmaceutic / Q000008:administration & dosage; D002170:Canada / Q000453:epidemiology; D000075202:Contraindications; D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality; D015912:Thrombolytic Therapy / Q000379:methods*
D000277:Adjuvants, Pharmaceutic; D005343:Fibrinolytic Agents